Viktor Curovic from Steno Diabetes Center Copenhagen presenting the ROTATE study at #ADA2022 a study to identify best first albuminuria-lowering treatment. Individual treatment-response can be improved! A collaboration w UMCG and others.Peter Rossing Hiddo Lambers Heersp

Peter Rossing from Steno Diabetes Center Copenhagen giving the #finerenone overview from the FIDELITY analysis with special focus on the combination with #GLP1 at the #ADA2022

Presenting data on Real Life Evaluation of @SGLT2i in Type 1 Diabetes in Denmark at the @ADA2022, Steno Diabetes Center Copenhagen

Sodium–glucose cotransporter 2 inhibitors as adjunct therapy for type ... sciencedirect.com/science/articl…

Next up at #EASD2022 from Steno Diabetes Center Copenhagen is Elisabeth Buur Stougaard on simulated outcome renal outcome from #SGLT inhibition using the Steno T1 risk engine.

Elisabeth B Stougaard presents data from T1D treated with sotagliflozin and the stenorisk for CVD and CKD and demonstrates benefit -we need RCT confirming this #EASD2022 Steno Diabetes Center Copenhagen

We calculated the incidence of DKA in people with T1D treated with #SGLT2i in Denmark in our study: Real life evaluation of sodium-glucose cotransporter 2 inhibition in type 1 diabetes and the risk of diabetic ketoacidosis ... ncbi.nlm.nih.gov/pmc/articles/P… #SDCC

Elisabeth Stougaard presenting modelling of #SGLTi benefit on kidney risk in #T1D using inTandem data w the Steno Diabetes Center Copenhagen kidney risk engine. Collab w Dorte Vistisen Peter Rossing and Lexicon.

Sotagliflozin, a dual SGLT1 and SGLT2 inhibitor, reduces the risk of cardiovascular and kidney disease, as assessed by the Steno T1 Risk Engine in adults with type 1 diabetes Frederik Persson, Dorte Vistisen, Peter Rossing dom-pubs.onlinelibrary.wiley.com/doi/10.1111/do…

Elisabeth B Stougaard #EDNSG23 testing if manipulation of gut microbiota with symbiotically improves#DKD - it does not 🥲Steno Diabetes Center Copenhagen

Just published: #SDCC Time Trends in the Incidence of Diabetic Ketoacidosis Leading to Hospital Admission Among Adults With Type 1 Diabetes—A Nationwide Danish Register Study diabetesjournals.org/care/article-a…

Declining incidensen of DM ketoacidosis in Denmark presented #EASD2023 by Elisabeth B Stougaard Good news Steno Diabetes Center Copenhagen Frederik Persson Dorte Vistisen Elisabeth Buur Stougaard

Forskere fra hele kongeriget vil revolutionere behandlingen af #type1diabetes 👏 🌟 Det sker med studiet Steno 1, som netop er påbegyndt. Læs mere: sdcc.dk/presse-og-nyhe… #steno1

The #Steno1 trial is now initiated! Aiming to include 2000 persons with type 1 diabetes at high risk of CVD and CKD and with the potential to change the way we treat complications to type 1 diabetes. #SDCC, #SDCA #SDCN, #SDCS #SDCO, #SDCG, #SDCF